The multivariate logistics regression analysis was applied to evaluate the performance of the panel of 4 genes (RAD50, RTEL, TERC and TRF1) as biomarkers for breast cancer prediction (Table 3). This evidence concerns the gene TERF1 and breast carcinoma.